Brain Connectivity Marker for Alzheimer's Disease
NCT06874231 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 120
Last updated 2025-03-17
Summary
The main purpose of this project is to establish whether changes in brain connectivity can be used to predict the development of Alzheimer's disease (AD).
Conditions
- Alzheimer Disease
Interventions
- OTHER
-
Neuroimaging
The investigators will collect imaging sequence, cognitive test scores, clinical data and biofluid samples
Sponsors & Collaborators
-
The Swedish Research Council
collaborator OTHER_GOV - lead OTHER
Eligibility
- Min Age
- 40 Years
- Max Age
- 85 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2023-04-01
- Primary Completion
- 2027-07-31
- Completion
- 2027-07-31
Countries
- Sweden
Study Locations
More Related Trials
-
Early Diagnosis of Alzheimer's Disease: Clinical, Neuropsychological and Neuroimaging Follow-up of a Cohort of Patients With an Isolated Memory Impairment
NCT00684281 ·Status: COMPLETED ·Phase: NA
-
MRI of Alzheimer's Disease Imaging Amyloid Plaques in Persons With and Without Memory Problems
NCT00413621 ·Status: COMPLETED
-
Biomarkers and Early Alzheimer's Disease
NCT00094952 ·Status: UNKNOWN
-
Activity of Cerebral Networks, Amyloid and Microglia in Aging and Alzheimer's Disease
NCT06224920 ·Status: COMPLETED
-
Evaluation of [123I] AV83 and SPECT in Patients With Alzheimer Disease in Comparison to Healthy Controls
NCT00448799 ·Status: COMPLETED ·Phase: PHASE1
-
Developing a New EEG Method for the Early Diagnosis of Dementia
NCT02426398 ·Status: RECRUITING
-
Intelligent Digital Tools for Screening of Brain Connectivity and Dementia Risk Estimation in People Affected by Mild Cognitive Impairment
NCT05159661 ·Status: RECRUITING
-
Cerebrospinal Fluid (CSF) Biomarkers Alzheimer's Disease (AD) and Non-AD Dementias
NCT01730430 ·Status: COMPLETED
-
Biomarkers of the Locus Coeruleus Nucleus: Links With Early Tau Pathology, Cognition and Alzheimer's Disease Risk
NCT07007208 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Use of [123I] AV39 and SPECT Imaging as a Marker of Protein Disposition in Subjects With Alzheimer Disease Compared to Healthy Subjects
NCT00439010 ·Status: COMPLETED ·Phase: PHASE1
-
Multimodal Imaging in the Study of Disorientation in the Hospital
NCT04387357 ·Status: UNKNOWN
-
A Study to Assess Regional Cerebral Blood Flow as an Alzheimer's Disease Biomarker Compared to Positron Emission Tomography in Patients With Mild-to-Moderate Alzheimer's Disease and Cognitively Normal Elderly Subjects (Study MK-0000-068)(COMPLETED)
NCT00757939 ·Status: COMPLETED ·Phase: PHASE1
-
Multi-modality MRI Study on Prediction for Mild Cognitive Impairment Conversion
NCT02353884 ·Status: COMPLETED
-
The Sunnybrook Dementia Study
NCT01800214 ·Status: ACTIVE_NOT_RECRUITING
-
Biomarker Study to Diagnose Alzheimer's Disease
NCT01874418 ·Status: UNKNOWN ·Phase: NA
-
Contributions of mTBI to Neurodegeneration Due to Chronic Traumatic Encephalopathy (CTE) and Alzheimer's Disease (AD)
NCT04124029 ·Status: RECRUITING
-
Magnetic Resonance Imaging for the Study of Patients With Neurological Disorders
NCT00001362 ·Status: COMPLETED
-
Orientation in AD Patients: PET-MR Study
NCT03030365 ·Status: UNKNOWN
-
Neuroimaging Markers of Alzheimer Disease: a Longitudinal Population Study
NCT01582919 ·Status: COMPLETED ·Phase: NA
-
New CSF Biomarkers for Alzheimer's Disease
NCT03621839 ·Status: RECRUITING
-
Blood Biomarker of Alzheimer's Disease (AD)
NCT03340571 ·Status: COMPLETED
-
ADNI: Alzheimer's Disease Neuroimaging Initiative
NCT00106899 ·Status: COMPLETED
-
Assess Fibrin in Brains With AD/ADRD
NCT05336695 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Developing Advanced Blood-Brain Barrier Permeability Imaging for Early AD
NCT03389698 ·Status: COMPLETED
-
Multi-modal Neuroimaging in Alzheimer's Disease
NCT01554202 ·Status: UNKNOWN ·Phase: NA